Nasivin Vicks Aloes I Eukaliptus (Oxymetazoline Hydrochloride)

Oxymetazoline hydrochloride, the active ingredient in Nasivin Vicks Aloes I Eukaliptus, is an alpha‑adrenergic agonist presented as a nasal decongestant for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Nasivin Vicks Aloes I Eukaliptus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline hydrochloride is an alpha‑adrenergic agonist used to treat nasal congestion by reducing swelling of the nasal mucosa. - Common cold: reduces nasal blockage and improves breathing. - Sinusitis: alleviates congestion and facilitates sinus drainage. - Allergic rhinitis: diminishes nasal swelling caused by allergens.

Oxymetazoline may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal passages. - Sneezing. - Mild headache. - Altered taste or bitter taste. - Minor nosebleeds.

Serious or Rare Side Effects: - Elevated blood pressure or hypertension. - Rapid heart rate or arrhythmia. - Severe nasal ulceration. - Allergic reactions including rash, itching or anaphylaxis. - Rebound congestion (rhinitis medicamentosa) with prolonged use. - Severe dizziness or fainting.

Before using Oxymetazoline, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use only if benefits outweigh potential risks. - Age restrictions: not recommended for children under 6 years. - Cardiovascular disease: avoid if uncontrolled hypertension is present. - Drug interactions: review all concomitant medications with a pharmacist or physician. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Oxymetazoline may interact with other medicines; assess the following.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: may increase blood pressure. - Sympathomimetic drugs: additive vasoconstrictive effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: possible masking of tachycardia. - Other nasal decongestants: heightened risk of rebound congestion. - Antihypertensives: may reduce their efficacy.